Keros Therapeutics Stock Price Prediction
| KROS Stock | USD 17.95 0.12 0.67% |
Momentum 51
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.96) | EPS Estimate Current Year 2.33 | EPS Estimate Next Year (2.94) | Wall Street Target Price 23.5 | EPS Estimate Current Quarter (0.92) |
Using Keros Therapeutics hype-based prediction, you can estimate the value of Keros Therapeutics from the perspective of Keros Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Keros Therapeutics using Keros Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Keros using crowd psychology based on the activity and movement of Keros Therapeutics' stock price.
Keros Therapeutics Short Interest
An investor who is long Keros Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Keros Therapeutics and may potentially protect profits, hedge Keros Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 15.7764 | Short Percent 0.1487 | Short Ratio 4.65 | Shares Short Prior Month 2.5 M | 50 Day MA 19.2394 |
Keros Therapeutics Hype to Price Pattern
Investor biases related to Keros Therapeutics' public news can be used to forecast risks associated with an investment in Keros. The trend in average sentiment can be used to explain how an investor holding Keros can time the market purely based on public headlines and social activities around Keros Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Keros Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Keros Therapeutics.
Keros Therapeutics Implied Volatility | 1.86 |
Keros Therapeutics' implied volatility exposes the market's sentiment of Keros Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Keros Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Keros Therapeutics stock will not fluctuate a lot when Keros Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Keros Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Keros because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Keros Therapeutics after-hype prediction price | USD 17.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Keros contract
Based on the Rule 16, the options market is currently suggesting that Keros Therapeutics will have an average daily up or down price movement of about 0.12% per day over the life of the 2026-03-20 option contract. With Keros Therapeutics trading at USD 17.95, that is roughly USD 0.0209 . If you think that the market is fully incorporating Keros Therapeutics' daily price movement you should consider acquiring Keros Therapeutics options at the current volatility level of 1.86%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Keros Therapeutics Basic Forecasting Models to cross-verify your projections. Keros Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Keros Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Keros Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Keros Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Keros Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Keros Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Keros Therapeutics' historical news coverage. Keros Therapeutics' after-hype downside and upside margins for the prediction period are 14.69 and 21.01, respectively. We have considered Keros Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Keros Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Keros Therapeutics is based on 3 months time horizon.
Keros Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Keros Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Keros Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Keros Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.32 | 3.16 | 0.10 | 0.02 | 11 Events / Month | 7 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
17.95 | 17.85 | 0.56 |
|
Keros Therapeutics Hype Timeline
Keros Therapeutics is now traded for 17.95. The entity has historical hype elasticity of -0.1, and average elasticity to hype of competition of 0.02. Keros is estimated to decline in value after the next headline, with the price expected to drop to 17.85. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.56%, whereas the daily expected return is now at 0.32%. The volatility of related hype on Keros Therapeutics is about 4213.33%, with the expected price after the next announcement by competition of 17.97. About 96.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.77. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Keros Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 11 days. Check out Keros Therapeutics Basic Forecasting Models to cross-verify your projections.Keros Therapeutics Related Hype Analysis
Having access to credible news sources related to Keros Therapeutics' direct competition is more important than ever and may enhance your ability to predict Keros Therapeutics' future price movements. Getting to know how Keros Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Keros Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RGNX | Regenxbio | (0.14) | 10 per month | 0.00 | (0.03) | 7.94 | (6.66) | 23.68 | |
| VSTM | Verastem | (0.54) | 11 per month | 0.00 | (0.05) | 5.83 | (6.80) | 29.79 | |
| ABSI | Absci Corp | (0.07) | 9 per month | 0.00 | (0.09) | 8.58 | (7.91) | 27.80 | |
| NAGE | Niagen Bioscience | 0.14 | 10 per month | 0.00 | (0.15) | 3.66 | (4.07) | 10.35 | |
| CTMX | CytomX Therapeutics | 0.10 | 10 per month | 4.15 | 0.17 | 10.08 | (8.51) | 30.43 | |
| VTYX | Ventyx Biosciences | (1.59) | 8 per month | 3.82 | 0.17 | 14.25 | (6.90) | 37.04 | |
| MLTX | MoonLake Immunotherapeutics | (1.39) | 9 per month | 3.57 | 0.15 | 8.68 | (6.36) | 35.46 | |
| CRVS | Corvus Pharmaceuticals | 0.91 | 11 per month | 2.90 | 0.13 | 9.63 | (6.97) | 174.29 | |
| OLMA | Olema Pharmaceuticals | 0.04 | 11 per month | 2.93 | 0.14 | 9.82 | (5.86) | 145.73 | |
| RIGL | Rigel Pharmaceuticals | 3.29 | 11 per month | 3.83 | 0.06 | 8.66 | (7.41) | 44.65 |
Keros Therapeutics Additional Predictive Modules
Most predictive techniques to examine Keros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Keros using various technical indicators. When you analyze Keros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Keros Therapeutics Predictive Indicators
The successful prediction of Keros Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Keros Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Keros Therapeutics based on analysis of Keros Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Keros Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Keros Therapeutics's related companies. | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 458.15 | 412.34 | 691.89 | PTB Ratio | 1.04 | 1.19 | 1.13 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.